XML 70 R54.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK COMPENSATION PLANS (Details)
12 Months Ended
May 06, 2024
shares
May 09, 2023
$ / shares
shares
May 03, 2022
$ / shares
shares
Dec. 31, 2024
USD ($)
Director
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
May 04, 2021
$ / shares
Stock Compensation Plans [Abstract]              
Number of directors in committee | Director       3      
Weighted Average Exercise Price [Abstract]              
Total intrinsic value of options exercised | $       $ 0 $ 137,000 $ 2,226,000  
Received cash from the exercise of options | $       0      
Tax benefit realized during the period | $       0      
Weighted Average Grant Date Fair Value [Abstract]              
Intrinsic value of awards | $       $ 197,400      
Employee and Director [Member]              
Options Outstanding [Abstract]              
Shares Outstanding (in shares) | shares       0      
Weighted Average Exercise Price (in dollars per shares)       $ 0      
Aggregate Intrinsic Value | $       $ 0      
Options Exercisable [Abstract]              
Shares Exercisable (in shares) | shares       0      
Weighted Average Exercise Price (in dollars per shares)       $ 0      
Aggregate Intrinsic Value | $       $ 0      
Restricted Stock Awards [Member]              
Stock Compensation Plans [Abstract]              
Share-based compensation expense | $       219,000 $ 254,000 $ 152,000  
Restricted Stock Awards [Member] | 2015 Equity Compensation Plan [Member]              
Weighted Average Grant Date Fair Value [Abstract]              
Unrecognized expense related to non-vested option shares | $       $ 63,000      
Award vesting period       4 months 2 days      
Class A Stock [Member] | Stock Options [Member]              
Shares [Roll Forward]              
Outstanding at beginning of period (in shares) | shares       0 6,750 83,000  
Granted (in shares) | shares       0 0 0  
Options exercised (in shares) | shares       0 (6,750) (76,250)  
Expired (in shares) | shares       0 0 0  
Outstanding at end of period (in shares) | shares       0 0 6,750  
Options exercisable at year end (in shares) | shares       0 0 6,750  
Weighted Average Exercise Price [Abstract]              
Outstanding at beginning of period (in dollars per shares)       $ 0 $ 21.86 $ 21.65  
Granted, weighted average exercise price (in dollars per share)       0 0 0  
Exercised/vested and released, weighted average exercise price (in dollars per shares)       0 21.86 21.63  
Expired/cancelled, weighted average exercise price (in dollars per share)       0 0 0  
Outstanding at end of period (in dollars per shares)       0 0 21.86  
Options exercisable at period end (in dollars per shares)       $ 0 $ 0 $ 21.86  
Class A Stock [Member] | Restricted Stock Awards [Member]              
Shares [Roll Forward]              
Outstanding at January 1, 2024 | shares       5,000      
Granted (in shares) | shares 5,000 5,000 5,000 5,000      
Exercised/vested and released | shares       (5,000)      
Expired/cancelled | shares       0      
Outstanding at December 31, 2024 | shares       5,000 5,000    
Exercisable/vested at December 31, 2024 | shares       0      
Weighted Average Grant Date Fair Value [Abstract]              
Outstanding at beginning of period (in dollars per shares)       $ 54.88      
Granted (in dollars per shares)       37.07      
Vested/Released (in dollars per shares)       54.88      
Cancelled (in dollars per shares)       0      
Outstanding at end of period (in dollars per shares)       37.07 $ 54.88    
Exercisable/vested at December 31, 2024       $ 0      
Period after grant date in which shares vested and were released 1 year 1 year 1 year        
Fair market value (in dollars per share)   $ 37.07 $ 54.88       $ 45.58